Review finds rodent BPC-157 ischemia data heterogeneous and hypothesis-generating
Authors searched literature through June 24, 2026 and declined to meta-analyze because organ models, doses, routes and timing varied too widely.
PR
By Priya Raman · Science Reporter
Sep 18 20:00 ETSource: International journal of molecular sciences
The wire
- 01A critical review in IJMS assessed rodent ischemia-reperfusion studies of BPC 157, reporting reduced oxidative injury, inflammatory and apoptotic markers, and changes in VEGF/VEGFR2-Akt-eNOS signaling across skeletal muscle, hippocampal, intestinal and hepatic models.
- 02Clinicians fielding BPC-157 questions now have a sourced summary that also catalogs the field's gaps, including FDA and WADA context.
- 03Authors note short observation periods, single-dose paradigms and incompletely characterized risk of bias, and classify BPC 157 only as an investigational candidate for further preclinical work.
From the source
Read at pubmed.ncbi.nlm.nih.govBPC 157 in Rodent Ischemia-Reperfusion Injury: A Critical Review of Preclinical Evidence
International journal of molecular sciences · 2026 Sep 19 · Demirtaş H et al.
Source URL https://pubmed.ncbi.nlm.nih.gov/42794771/
